BUSINESS BRIEFING / PHARMACEUTICALS
TIMES WIRE SERVICES
Johnson & Johnson won approval in Sweden and Finland for the first prescription pill to treat premature ejaculation, three years after U.S. regulators rejected the drug, the company said.
The drug maker expects to win clearance for dapoxetine, to be sold as Priligy, in five more European nations and has applied for approval in Canada, Australia, Mexico, Turkey and six other countries, a spokesman for New Brunswick, N.J.-based J&J; said.
